EUVIMEDEUVIMED entdecken
Crossref

Trimetallic Cu–Zn–Fe Layered Double Hydroxide Nanocarrier Enabling On-Demand Anticancer Drug Release with Prolonged Therapeutic Windows for Precision Oncology

Swapan Maity, Souvik Chowdhury, Dipesh Kumar Dubey, Hitesh Harsukhbhai Chandpa, Jairam Meena iD, Akshita Upreti, Rohan Chand Sahu, Ashish Kumar Agrawal, Manas Kumar Santra, Dipankar Chattopadhyay iD, Arun Kumar Nandi iD, Pralay Maiti iD

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c13200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Swapan Maity und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Polymer Science and Technology, University of Calcutta, 92 A.P.C. Road, Kolkata700009, India. Hauptthemen laut MEDLINE: Hydroxides, Doxorubicin, Drug Carriers, Antineoplastic Agents. Die Arbeit nennt 69 Literaturangaben. Gefördert von: Anusandhan National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical oncology faces a critical technological bottleneck driven by the rapid emergence of therapy-resistant tumors. Melanoma, in particular, remains a highly aggressive malignancy with pronounced metastatic potential and poor responsiveness to traditional therapy, signify the demand for advanced therapeutic strategies. Herein, we report a multifunctional nanoplatform integrating ternary layered double hydroxides (LDHs) with an injectable hydrogel system for localized and controlled melanoma therapy. The engineered trimetallic Cu–Zn–Fe LDHs (CZF) exhibit tunable physicochemical properties, enabling efficient drug intercalation, enhanced structural stability, and stimuli-responsive release within the tumor microenvironment. Doxorubicin (Dox) loaded LDHs (CZF@Dox) demonstrate high loading efficiency and sustained release, minimizing premature leakage and systemic toxicity. Computational insights from molecular dynamics and machine learning-assisted modeling reveal optimized host–guest interactions for improved delivery performance. In vitro studies confirm excellent biocompatibility toward normal 3T3-L1 cells (∼10% cell death at 20 μg/mL, 72 h), alongside significant cytotoxicity against B16F10 and SiHa cancer cells (∼80–85% cell death at the same conditions). In vivo evaluation further demonstrates effective tumor suppression with prolonged dosing intervals (96 h). Overall, this platform offers a predictive, minimally invasive, and efficient strategy for next-generation melanoma therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydroxidesDoxorubicinDrug CarriersAntineoplastic AgentsNanoparticlesAnimalsMiceCopperHumansDrug LiberationZincCell Line, TumorIronMelanoma, ExperimentalDelayed-Action Preparations

Stichwörter der Autor:innen

Cu–Zn–Fe layered double hydroxidecellular uptakecontrolled drug deliveryinjectable hydrogelnext-generation melanoma treatmenttargeted cancer therapy

Substanzen

HydroxidesDoxorubicinCopperDrug CarriersZincAntineoplastic AgentsIronDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Polymer Science and Technology, University of Calcutta, 92 A.P.C. Road, Kolkata700009, India.
  • School of Materials Science and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi221005, India.
  • Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi221005, India.
  • Department of Biological Sciences, Birla Institute of Technology and Science, Pilani (K. K Birla Goa Campus), Goa403726, India.
  • National Centre for Cell Science , Pune, Maharashtra411007, India.
  • School of Materials Sciences, Indian Association for the Cultivation of Science, Jadavpur700 032, India.

ORCID-Profile: Jairam Meena, Dipankar Chattopadhyay, Arun Kumar Nandi, Pralay Maiti

Förderung

  • Anusandhan National Research Foundation

Zitieren

APA

Maity, S., Chowdhury, S., Dubey, D. K., Chandpa, H. H., Meena, J., Upreti, A., Sahu, R. C., Agrawal, A. K., Santra, M. K., Chattopadhyay, D., Nandi, A. K., & Maiti, P. (2026). Trimetallic Cu–Zn–Fe Layered Double Hydroxide Nanocarrier Enabling On-Demand Anticancer Drug Release with Prolonged Therapeutic Windows for Precision Oncology. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c13200

Vancouver

Maity S, Chowdhury S, Dubey DK, Chandpa HH, Meena J, Upreti A, et al. Trimetallic Cu–Zn–Fe Layered Double Hydroxide Nanocarrier Enabling On-Demand Anticancer Drug Release with Prolonged Therapeutic Windows for Precision Oncology. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c13200

BibTeX
@article{Maity2026,
  author = {Maity, Swapan and Chowdhury, Souvik and Dubey, Dipesh Kumar and Chandpa, Hitesh Harsukhbhai and Meena, Jairam and Upreti, Akshita and Sahu, Rohan Chand and Agrawal, Ashish Kumar and Santra, Manas Kumar and Chattopadhyay, Dipankar and Nandi, Arun Kumar and Maiti, Pralay},
  title = {Trimetallic Cu–Zn–Fe Layered Double Hydroxide Nanocarrier Enabling On-Demand Anticancer Drug Release with Prolonged Therapeutic Windows for Precision Oncology},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c13200}
}
Kostenlos starten →